Management of thymic tumors: A survey of current practice among members of the european society of thoracic surgeons

Journal of Thoracic Oncology

Volumn 6, Issue 3, 2011, Pages 614-623

  Ruffini, Enrico ^a   Van Raemdonck, Dirk ^b   Detterbeck, Frank ^c   Rocco, Gaetano ^d   Thomas, Pascal ^e   Venuta, Federico ^f  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c YALE UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e AIX MARSEILLE UNIVERSITY   (France)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Surgery; Survey; Thymic carcinoma; Thymoma

Indexed keywords

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; LUNG RESECTION; PATHOLOGIST; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; THORAX SURGERY; THYMOMA; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 79951769952     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318207cd74     Document Type: Article

References (50)

1. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-551. (Pubitemid 36578561)
2. Venuta F, Anile M, Diso D, et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 2010;37:13-25.
3. Wright CD. Management of thymomas. Crit Rev Oncol Hematol 2008; 65:109-120.
4. Tomiyama N, Müller NL, Ellis SJ, et al. Invasive and noninvasive thymoma: distinctive CT features. J Comput Assist Tomogr 2001;25: 388-393. (Pubitemid 32440791)
5. Rosai J, Sobin LH. Histological typing of tumours of the thymus. In J Rosai, L Sobin (Eds.), World Health Organization, International Histological Classification of Tumours, 2nd Ed. Berlin, Springer-Verlag, 1999. Pp. 9-14.
6. Marx A, Strobel P, Zettl A, et al. Thymomas. In WD Travis, E Brambilla, HK Muller-Hermelink, et al. (Eds.), World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Thymus and Heart, Vol. 7. Lyon: IARC press, 2004. Pp. 152-153.
7. Muller-Hermelink HK, Strobel P, Zetti A. Combined thymic epithelial tumours. In WD Travis, E Brambilla, HK Muller-Hermelink, et al. (Eds.), Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart (WHO Classification of Tumours). Lyon, France: IARC Press, 2004. Pp. 196-201.
8. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymoma with special reference to their clinical stages. Cancer 1981;48:2485-2492. (Pubitemid 12228012)
9. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-367. (Pubitemid 24153752)
10. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-nodemetastasis classification of thymoma. Cancer 1991;68:1984-1987.
11. Gamondès JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg 1991;5:124-131.
12. Puri V, Meyers BF. Utility of positron emission tomography in the mediastinum: moving beyond lung and esophageal cancer staging. Thorac Surg Clin 2009;19:7-15.
13. Kubota K, Yamada S, Kondo T, et al. PET imaging of primary mediastinal tumours. Br J Cancer 1996;73:882-886. (Pubitemid 26110157)
14. Detterbeck F, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77: 1860-1869. (Pubitemid 38530055)
15. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-632. (Pubitemid 34132289)
16. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumours: importance of invasion, World Health Organization histology and size. J Thorac Cardiovasc Surg 2005;130:1413-1421. (Pubitemid 41543213)
17. Rea F, Marulli G, Girardi R, et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004;26: 412-418. (Pubitemid 39024669)
18. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-884. (Pubitemid 37100765)
19. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-156.
20. Davenport E, Malthaner RA. The role of surgery in the management of thymoma. A systematic review. Ann Thorac Surg 2008;86:673-684. (Pubitemid 351978021)
21. Cardillo G, Carleo F, Giunti R, et al. Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages II and IVa). Eur J Cardiothorac Surg 2010;37:819-823.
22. Margaritora S, Cesario A, Cusumano G, et al. Thirty-five year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg 2010;89:245-252.
23. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-384. (Pubitemid 26301849)
24. Nakahara K, Ohno K, Hashimoto J, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988;95:1041-1047.
25. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999;230:562-574. (Pubitemid 30191851)
26. Okumura M, Miyoshi S, Takeuchi Y, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 1999;117:605-613. (Pubitemid 29117544)
27. Yagi K, Hirata T, Fukuse T, et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 1996;61:521-524.
28. De Giacomo T, Mazzesi G, Venuta F, et al. Extended operation for recurrent thymic carcinoma presenting with intracaval growth and intracardiac extension. J Thorac Cardiovasc Surg 2007;134:1364-1365. (Pubitemid 47633615)
29. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76:1866-1872; discussion 1872.
30. Curran WJ Jr, Kornstein MJ, Brooks JJ, et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-1727. (Pubitemid 19089051)
31. Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-1641; discussion 1641-1642.
32. Haniuda M, Miyazawa M, Yoshida K, et al. Is postoperative radiotherapy for thymoma effective? Ann Surg 1996;224:219-224.
33. Venuta F, Rendina EA, Pescarmona EO, et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 1997;64:1585-1591; discussion 1591-1592.
34. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993;106:543-549. (Pubitemid 23277629)
35. Lucchi M, Ambrogi MC, Duranti L, et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg 2005;79:1840-1844. (Pubitemid 40804146)
36. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093-3099. (Pubitemid 27377501)
37. Loehrer PJ Sr, Kim K, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994;12:1164-1168. (Pubitemid 24173929)
38. Lucchi M, Basolo F, Mussi A. Surgical treatment of pleural recurrence from thymoma. Eur J Cardiothorac Surg 2008;33:707-711.
39. Venuta F, Rendina EA, Coloni GF. Multimodality treatment of thymic tumors. Thorac Surg Clin 2009;19:71-81
40. Lucchi M, Davini F, Ricciardi R, et al. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg 2009;137:1185-1189.
41. Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 2006;82:1234-1239. (Pubitemid 44402351)
42. Ishikawa Y, Matsuguma H, Nakahara R, et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg 2009; 88:952-957.
43. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997;113:55-63. (Pubitemid 27034342)
44. Ruffini E, Filosso PL, Oliaro A. The role of surgery in recurrent thymic tumors. Thorac Surg Clin 2009;19:121-131.
45. Regnard JF, Zinzindohoue F, Magdeleinat P, et al. Results of reresection for recurrent thymomas. Ann Thorac Surg 1997;64:1593-1598.
46. Kirschner PA. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 1990;49:550-554.
47. Moran CA, Suster S. Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am 2008;22:393-407. (Pubitemid 351726403)
48. Liu HC, Hsu WH, Chen YJ, et al. Primary thymic carcinoma. Ann Thorac Surg 2002;73:1076-1081.
49. Chalabreysse L, Roy P, Cordier JF, et al. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002;26: 1605-1611. (Pubitemid 35387223)
50. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134-1140. (Pubitemid 37305702)